COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Prognosis of Behavioral Addiction in Parkinson's Disease (PROBA-PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02671240
Recruitment Status : Recruiting
First Posted : February 2, 2016
Last Update Posted : May 22, 2017
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:

Our hypothesis is that the conventional treatment of Behavioral Addiction in Parkinson's disease is often not effective, and that affects the motor aspects (worsening akinéto-rigid syndrome and / or worsening of dyskinesia due to higher levodopa doses to compensate for the drop in behavioral addictions) and non-motor (withdrawal syndrome dopamine agonist) anxiously including apathy.

Our goal is to describe the natural history of Behavioral Addiction under the effect of the evolution of the disease and adapt treatment according to the prior art, through a study of a larger population of patients than in the few published studies.

Condition or disease

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Retrospective
Actual Study Start Date : October 24, 2016
Estimated Primary Completion Date : October 24, 2021
Estimated Study Completion Date : October 24, 2021

Resource links provided by the National Library of Medicine

- Patients with behavioral addiction
- Patients with no behavioral addiction

Primary Outcome Measures :
  1. Survival time before disappearance of behavioral addiction defined by a score of less than 2 on the scale of behavioral assessment of Parkinson's disease [ Time Frame: 12 months after selection ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with Parkinson's disease who developed or not a behavioral addiction

Inclusion criteria:

  • Age greater than or equal to 30 years
  • Parkinson's disease according to the criteria of UKPDSBB
  • Time evolution of the top disease or equal to 5 years

Exclusion criteria:

  • Lack of Parkinson's disease and atypical parkinsonism
  • Patient not previously included in PD-BADGE

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02671240

Layout table for location contacts
Contact: Mathieu ANHEIM, MD, PhD 33 (0)3 88 12 85 32

Layout table for location information
Service de Neurologie Recruiting
Strasbourg, France, 67098
Contact: Mathieu ANHEIM, MD, PhD    03 88 12 85 32   
Sponsors and Collaborators
University Hospital, Strasbourg, France
Layout table for investigator information
Study Director: Mathieu ANHEIM, MD, PhD University Hospital, Strasbourg, France
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France Identifier: NCT02671240    
Other Study ID Numbers: 6246
First Posted: February 2, 2016    Key Record Dates
Last Update Posted: May 22, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by University Hospital, Strasbourg, France:
Parkinson disease
behavioral addiction
akinéto-rigid syndrome
dopamine agonist
Additional relevant MeSH terms:
Layout table for MeSH terms
Behavior, Addictive
Compulsive Behavior
Impulsive Behavior